Bioclinica Acquires Saliency to Accelerate Digital Diagnostic Development
Bioclinica will integrate the company’s advanced AI technology into its Imaging Platform to support a growing portfolio of pharmaceutical and medical device clients.
Florida / New York
Ph: 561.316.3330
Medical Device News Magazine is the leading resource for medical device M&A information. We provide coverage of all the latest deals, as well as insights and analyses from industry experts.
Our readers rely on us for the most up-to-date information on the medical device market. We are focused on delivering the most comprehensive news coverage possible. Whether you are a CEO, CFO, investor, or employee of a medical device company, MDNM is the source you can trust for all your merger and acquisition news.
Bioclinica will integrate the company’s advanced AI technology into its Imaging Platform to support a growing portfolio of pharmaceutical and medical device clients.
“Syntactx is very proud to join NAMSA, a long-recognized industry leader in CRO medical device development and clinical research services,” stated Dr. Kenneth Ouriel, President and CEO of Syntactx.
Chairman and CEO Kevin Conroy said, “Bringing Thrive into the Exact Sciences family marks a giant leap toward blood-based, multi-cancer screening becoming a reality and eventually the standard of care.
Founded in 1999, Degradable Solutions AG, is headquartered in Schlieren, Switzerland, and has been part of the Sunstar Group since 2011.
December 28, 2020 United Therapeutics Corporation announced today an agreement to acquire a Rare Pediatric Disease Priority Review Voucher (PRV), which it plans to use
The acquisition of Pacific Stem Cells, LLC would further expand Dalrada Health’s product and services offerings in the healthcare industry.
Copyright © 2025 Medical Device News Magazine, a division of PTM Healthcare Marketing, Inc. All Rights Reserved
Hours:
M – F 8 am – 5 pm
Florida / New York
Phone: 561.316.3330